Clinical Trial Update: A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluating safety, dose conversion, and dose individualization of Duragesic (fentanyl transdermal patch) in children with chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Duragesic (fentanyl transdermal system)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED